![Akanda Corp](https://storage.googleapis.com/dealroom-images-production/d9/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA3LzAxLzk4ZDgwZDM3YzIxZDFlYzYyNDlmZDBmYmU2YmZkNDI1.png)
Akanda Corp
VerifiedUSD | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 1909 % | 6223 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (68212 %) | (15684 %) | (626 %) |
Profit | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (111570 %) | (19626 %) | (445 %) |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
N/A | $0.0 | round | |
investor | $0.0 | round | |
* | N/A | $2.5m | Post IPO Equity |
Total Funding | 000k |
Related Content
Recent News about Akanda Corp
EditAkanda Corp is a seed-to-patient supply chain business, connecting patients in the UK and Europe with medical cannabis and wellness products. Akanda's purpose-built indoor grow facility in Portugal is the only one of its kind that can produce EU GMP medical cannabis equivalent to the recreational grades available in North America. They are dedicated to providing high quality and efficacious products to improve quality of life for consumers in legal markets. Akanda also works with leading prescribing doctors, digital pain clinics and distribution partners to bring cannabis-based medicine to international patients. What sets them apart from other businesses in the industry is their ability to produce EU GMP medical cannabis, as well as their dedication to providing high quality and efficacious products to improve quality of life for consumers in legal markets.